Completed NA INTERVENTIONAL 1-arm NCT05081947

Assessing the Acceptability and Feasibility of COMPASS

Assessing the Acceptability and Feasibility of COMPASS, a Transdiagnostic Web-based Intervention for the Management of Depression and Anxiety in Long-term Conditions, in Community-based Heart Failure Patients

Sponsor: King's College London

Conditions Anxiety Depression Heart Failure

Interventions COMPASS

Updated 4 times since 2021 Last updated: Oct 11, 2022 Started: Nov 11, 2021 Primary completion: Apr 1, 2022 Completion: Apr 1, 2022

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Anxiety and Depression, this trial is completed. The trial is conducted by King's College London and has accumulated 4 data snapshots since 2021. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Nov 2022 — Jul 2024 [monthly]

Completed NA

Status: Not Yet Recruiting → Completed
Nov 2021 — Nov 2022 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

King's College London

Data source: King's College London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• London, United Kingdom